Who it's for
Built for the organisations carrying the outcome — and the cost — of chronic disease.
Renvia is a B2B platform. We partner with UK NHS commissioners, private hospital groups, and insurers rather than selling directly to patients.
NHS ICBs & trusts
Extend your virtual ward to the cardio-renal-metabolic cohort.
Renvia deploys as a specialty-focused virtual ward, targeting the small patient population responsible for a disproportionate share of non-elective admissions. Configurable to local pathways and DTAC-aligned from day one.
- Aligned with NHS England virtual ward guidance
- Configurable escalation triggers per service
- FHIR-based EHR interoperability
- Clinical safety per DCB0129 / DCB0160
Private hospital groups
A coordinated long-term monitoring service line for insured members.
Differentiate cardiology, nephrology and diabetes services with an integrated post-discharge and long-term monitoring pathway that stabilises high-utiliser members and demonstrates measurable outcomes.
- Turnkey service line for complex members
- Coordinated across specialty consultants
- Outcome and utilisation dashboards
- White-label options available
Insurers & payers
Bend the cost curve on your highest-risk members.
Cardio-renal-metabolic comorbidity drives disproportionate claim spend. Renvia provides a clinician-in-the-loop intervention that reduces avoidable admissions and demonstrates value with per-member-per-month reporting.
- Cohort targeting by risk stratification
- PMPM outcome and cost reporting
- Deployed via provider network
- Data-sharing agreements ready
Partner with Renvia